Biomatics Capital Closes $200M Fund, Plans Genomics, Digital Health Investments

Marco Green
Марта 20, 2017

Venture capital firm Biomatics Capital Partners said today that it has closed an initiatory fund of $200 million, surpassing an initial target of $150 million. Founded by former Genentech neuroscientists, it has raised more than $200 million from investors so far.

With the recent explosion of genomic data and development of platforms to organize that data, Biomatics is more heavily focused on genomics than anything else, but Sunderland told MobiHealthNews that the company is dedicating a significant amount of attention on digital health innovation. Boris Nikolic is a physician who previously served as chief advisor for science and technology to Bill Gates, investing in both for-profit and not-for-profit outfits.

Along with reimbursement awareness and an understanding of how technology and data can enable clinical change, Sunderland said Biomatics wants to see companies that are also cognizant of another key aspect of healthcare.

Sunderland said, "It's our goal to seek out radically innovative solutions-the outliers". Together, the two bring a rich experience of handling a very diverse portfolio of companies to the table. Investments in each company could grow up to $20 million as the companies expand. Similarly, Sunderland headed the Bill and Melinda Gates foundation's $1.5 billion strategic investment pool and invested into companies that dealt with global health and education issues. Co-founders and General Partners Dr. Boris Nikolic and Julie Sunderland have invested together in emerging technology, health care and life science ventures since 2010, leveraging their deep technical knowledge and partnering expertise with an established network of leading academics, pharma executives and venture capital firms. "By combining the best of science with sound investment practices, we are looking to create extraordinary financial value for our investors and a pathway to better patient outcomes".

This latest fund comes just a few weeks after fellow U.S. VC firm Lux Capital announced a fresh $400 million fund with similar aspirations - Lux backs "contrarians and outsiders from science and tech" with a focus on cutting edge "high-risk" technology.

Other reports by

Discuss This Article